Heron Therapeutics | Capitale Sociale E Riserve

Prezzo Delle Azioni
1.30
Cambio Giornaliero
0.02 1.17%
Mensile
-13.09%
Annuale
-21.99%
Q1 Previsione
2.71




Capitale Sociale E Riserve Cambiamento Data
ALKERMES USD 1.73B 108.85M 2025-09
Alnylam Pharmaceuticals USD 233.89M 16.7M 2025-09
Amarin USD 458.89M 6.03M 2025-09
ANI Pharmaceuticals USD 505.82M 69.06M 2025-09
Anika Therapeutics USD 146.8M 867K 2025-09
Arrowhead Research USD 568.42M 102.37M 2025-12
Eisai JPY 889.64B 35.21B 2025-12
Esperion Therapeutics USD -451.36M 17.85M 2025-09
GlaxoSmithKline GBP 16.38B 229M 2025-12
Heron Therapeutics USD 14.88M 42.14M 2025-09
Insmed USD 945.57M 304.16M 2025-09
Ligand Pharmaceuticals USD 950.17M 121.64M 2025-09
Merck USD 51.85B 2.79B 2025-09
Nektar Therapeutics USD 85.09M 109.3M 2025-09
Neurocrine Biosciences USD 3B 309.3M 2025-09
Omeros USD -228.68M 15.13M 2025-06
Pacira USD 727.21M 30.55M 2025-09
Regeneron Pharmaceuticals USD 31.26B 299.1M 2025-12
Roche Holding CHF 33.8B 758M 2025-12
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Surmodics USD 118.9M 753K 2024-09
Ultragenyx Pharmaceutical USD 9.16M 142.13M 2025-09
Veracyte USD 1.26B 36.61M 2025-09
Vertex Pharmaceuticals USD 17.32B 143.4M 2025-09


Heron Therapeutics Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.